|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, May 27, 2016 ) Publisher's, 'Bronchiectasis - Pipeline Review, H1 2016', provides an overview of the Bronchiectasis pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Bronchiectasis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Bronchiectasis and features dormant and discontinued projects.
Publisher's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Other Key Points in Report:
- The report provides a snapshot of the global therapeutic landscape of Bronchiectasis
- The report reviews pipeline therapeutics for Bronchiectasis by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Bronchiectasis therapeutics and enlists all their major and minor projects
- The report assesses Bronchiectasis therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Bronchiectasis
Ask for Sample Report @ http://www.reportsweb.com/inquiry&RW0001242079/sample
Table of Content: An Overview
Table of Contents 2
List of Tables 5
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
Bronchiectasis Overview 7
Therapeutics Development 8
Pipeline Products for Bronchiectasis - Overview 8
Bronchiectasis - Therapeutics under Development by Companies 9
Bronchiectasis - Pipeline Products Glance 10
Late Stage Products 10
Clinical Stage Products 11
Early Stage Products 12
Bronchiectasis - Products under Development by Companies 13
Bronchiectasis - Companies Involved in Therapeutics Development 14
Alitair Pharmaceuticals, Inc. 14
Bayer AG 15
Grifols, S.A. 16
Insmed Incorporated 17
Kamada Ltd. 18
Nostrum Pharmaceuticals, LLC 19
Polyphor Ltd. 20
Raptor Pharmaceutical Corp. 21
Ask for Discount on Report @ http://www.reportsweb.com/inquiry&RW0001242079/discount
Recipharm AB 22
Savara Inc. 23
Therabron Therapeutics, Inc. 24
Vertex Pharmaceuticals Incorporated 25
Bronchiectasis - Therapeutics Assessment 26
Assessment by Monotherapy Products 26
Assessment by Target 27
Assessment by Mechanism of Action 29
Assessment by Route of Administration 31
Assessment by Molecule Type 33
Drug Profiles 35
alpha-1 proteinase inhibitor (human) second generation - Drug Profile 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
amikacin sulfate - Drug Profile 38
Product Description 38
Mechanism of Action 38
R&D Progress 38
ARD-3150 - Drug Profile 43
Product Description 43
Mechanism of Action 43
R&D Progress 43
CG-1011 - Drug Profile 45
Purchase Complete Report @ http://www.reportsweb.com/buy&RW0001242079/buy/2000
About Us:
ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.
Contact Us:
Email: sales@reportsweb.com
Call: +1-646-491-9876
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
